PCA CPP study materials
PCA CPP study resources

Nivolumab Waste, Billing Units, and the JW Modifier

PCA CPP · Put your knowledge to work in context.

All case studies

Nivolumab Waste, Billing Units, and the JW Modifier

Mrs. P, BSA 1.8 m2, is treated with nivolumab 240 mg IV. The pharmacy supplies 100 mg/10 mL vials; the nurse uses three vials (300 mg) and discards 60 mg. The drug is reported with HCPCS J9299 (injection, nivolumab, 1 mg). The first claim was submitted as J9299 with 240 units and no waste line. The payer denied the claim, stating that the units billed exceeded the dose documented. The practice also omitted the NDC. The charge master shows the drug was purchased and the waste was witnessed. The coder must correct the claim and explain the JW modifier to the billing staff.

1. Calculate the correct billing units and explain how the administered dose and discarded drug should appear on the claim.

Read the worked answer

J9299 is billed in 1 mg units. The administered dose is 240 mg, so that is 240 units. The discarded amount is 60 mg, which is 60 units. The total drug units are 300. The claim should have two line items: J9299 x 240 for the dose administered to the patient, and J9299-JW x 60 for the discarded drug. The JW modifier identifies drug amount discarded and not administered. The total units across both lines equal the 300 mg purchased from three vials. If the payer requires a single line, follow the payer's instruction, but the standard approach is a separate JW line. Do not bill 300 units on one line without identifying the waste; that is what triggered the denial. The documentation should show the vial sizes, the dose, and the witnessed waste.

2. What are the JW modifier and NDC requirements, and where do they go on the claim?

Read the worked answer

JW is a HCPCS Level II modifier that reports discarded drug or biological from a single-use vial. It is appended to the drug code on the waste line. It is not used for multi-dose vials or for drug that was not purchased. The NDC is reported with qualifier N4 and the 11-digit NDC in the NDC field on the claim, usually for each drug line. The NDC should match the vial(s) used. Some payers require the NDC on both the administered and waste lines; others require it on the first drug line only. The coder should verify the payer's companion guide. The claim should also include the drug's HCPCS code, the dose, the units, and the date of service. If the NDC is missing, the payer may deny or reject the claim even when the units are correct.

3. How should the practice handle the denial, and what process change would prevent a recurrence?

Read the worked answer

Do not write off the claim or bill the patient yet. Correct and resubmit the claim with the two J9299 lines, the JW modifier on the 60-unit waste line, and the NDC. Attach or reference the medication administration record, the pharmacy purchase record, and the witnessed waste documentation if the payer requests it. If the payer's denial was a coding rejection rather than a medical necessity denial, a corrected claim is usually the right path; if the payer requires an appeal, file within the appeal deadline. The root cause is a charge-entry process that captured only the administered dose and omitted waste and NDC. The practice should build an edit in the charge capture system that prompts for vial size, total drug used, discarded amount, and NDC whenever a single-use vial drug is charged. Education should cover the difference between administered units and purchased units.